Aleman, A., Kahn, R. S. ,Selten, J. P. 2003. Sex differences in the risk of
schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry. 60 (6), 565-71.
Allebeck, P., Varla, A. ,Wistedt, B. 1986. Suicide and violent death among patients with schizophrenia. Acta Psychiatr Scand 74 (1), 43-49.
Allison, D. B., Fontaine, K. R., Heo, M., Mentore, J. L., Cappelleri, J. C., Chandler, L.
P., Weiden, P. J. ,Cheskin, L. J. 1999. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry. 60 (4), 215-220.
APA. (2000). "American Psychiatric Association http://www.psych.org/."
APA 2003. American Psychiatric Association (APA). Practice guideline for the assessment and treatment of patients with suicidal behaviors. Am J Psychiatry.
(160 (suppl 11)), 1-60.
Auquier, P., Lancon, C., Rouillon, F. ,Lader, M. 2007. Mortality in schizophrenia.
Pharmacoepidemiol Drug Saf. 16 (12), 1308-1312.
Banki, C. M., Arato, M., Papp, Z. ,Kurcz, M. 1984. Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. J Affect Disord. 6 (3-4), 341-50.
Banki, C. M., Arato, M. ,Kilts, C. D. 1986. Aminergic studies and cerebrospinal fluid cations in suicide. Ann N Y Acad Sci. 487 221-30.
Barr, C. E., Mednick, S. A. ,Munk-Jorgensen, P. 1990. Exposure to influenza
epidemics during gestation and adult schizophrenia. A 40-year study. Arch Gen Psychiatry. 47 (9), 869-74.
Baxter, D. ,Appleby, L. 1999. Case register study of suicide risk in mental disorders.
British Journal of Psychiatry. 175 322-6.
Bjerkenstedt, L., Gullberg, B., Härnryd, C. ,Sedvall, G. 1977. Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene. Arch Psychiatr Nervenkr. 224 (2), 107-18.
Bradbury, T. N. ,Miller, G. A. 1985. Season of birth in schizophrenia: a review of evidence, methodology, and etiology. Psychol Bull. 98 (3), 569-94.
Brown, G. L. ,Linnoila, M. I. 1990. CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. J Clin Psychiatry. 51 Suppl 31-41;
discussion 42-43.
Brown, S. 1997. Excess mortality of schizophrenia. A meta-analysis. Br J Psychiatry.
171 502-8.
Brown, S., Birtwistle, J., Roe, L. ,Thompson, C. 1999. The unhealthy lifestyle of people with schizophrenia. Psychol Med. 29 (3), 697-701.
Bulat, M. ,Zivkovic, B. 1971. Origin of 5-hydroxyindoleacetic acid in the spinl fluid.
Science. 173 (998), 738-40.
Caldwell, C. B. ,Gottesman, II 1990. Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr Bull. 16 (4), 571-89.
Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M. ,Carlsson, M. L.
2001. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol. 41 237-60.
Carpenter, W. T., Jr. ,Buchanan, R. W. 1994. Schizophrenia. N Engl J Med. 330 (10), 681-90.
Cooper, S. J., Kelly, C. B. ,King, D. J. 1992. 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia.
Lancet. 340 (8825), 940-1.
Dalman, C., Thomas, H. V., David, A. S., Gentz, J., Lewis, G. ,Allebeck, P. 2001.
Signs of asphyxia at birth and risk of schizophrenia. Population-based case-control study. Br J Psychiatry. 179 403-8.
Dalman, C. ,Allebeck, P. 2002. Paternal age and schizophrenia: further support for an association. Am J Psychiatry. 159 (9), 1591-2.
De Hert, M., McKenzie, K. ,Peuskens, J. 2001. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr Res. 47 (2-3), 127-34.
Drake, R. E. ,Ehrlich, J. 1985. Suicide attempts associated with akathisia. Am J Psychiatry. 142 (4), 499-501.
Ekholm, B., Ekholm, A., Adolfsson, R., Vares, M., Ösby, U., Sedvall, G. C. ,Jönsson, E. G. 2005. Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry. 59 (6), 457-464.
Ekholm, B., Ekholm, A., Adolfsson, R., Vares, M., Ösby, U., Sedvall, G. C. ,Jönsson, E. G. 2005. Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry. 59 (6), 457-64.
Engström, G., Alling, C., Blennow, K., Regnell, G. ,Träskman-Bendz, L. 1999.
Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.
Eur Neuropsychopharmacol. 9 (5), 399-405.
Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindström, L. H. ,Engberg, G. 2001.
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett. 313 (1-2), 96-8.
Faustman, W. O., Ringo, D. L. ,Faull, K. F. 1993. An association between low levels of 5-HIAA and HVA in cerebrospinal fluid and early mortality in a diagnostically mixed psychiatric sample. Br J Psychiatry. 163 519-521.
Hansen, V., Jacobsen, B. K. ,Arnesen, E. 2001. Cause-specific mortality in psychiatric patients after deinstitutionalisation. Br J Psychiatry. 179 438-43.
Harkavy-Friedman, J. M., Restifo, K., Malaspina, D., Kaufmann, C. A., Amador, X. F., Yale, S. A. ,Gorman, J. M. 1999. Suicidal behavior in schizophrenia:
characteristics of individuals who had and had not attempted suicide. Am J Psychiatry. 156 (8), 1276-8.
Harris, E. C. ,Barraclough, B. 1997. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 170 205-28.
Haw, C., Hawton, K., Sutton, L., Sinclair, J. ,Deeks, J. 2005. Schizophrenia and deliberate self-harm: a systematic review of risk factors. Suicide Life Threat Behav. 35 (1), 50-62.
Hawton, K., Sutton, L., Haw, C., Sinclair, J. ,Deeks, J. J. 2005. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry. 187 9-20.
Hawton, K. ,van Heeringen, K. 2009. Suicide. Lancet. 373 (9672), 1372-81.
Heilä, H., Isometsä, E. T., Henriksson, M. M., Heikkinen, M. E., Marttunen, M. J.
,Lönnqvist, J. K. 1997. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am J Psychiatry. 154 (9), 1235-42.
Hilmas, C., Pereira, E. F., Alkondon, M., Rassoulpour, A., Schwarcz, R. ,Albuquerque, E. X. 2001. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression:
physiopathological implications. J Neurosci. 21 (19), 7463-73.
Hunt, I. M., Kapur, N., Windfuhr, K., Robinson, J., Bickley, H., Flynn, S., Parsons, R., Burns, J., Shaw, J. ,Appleby, L. 2006. Suicide in schizophrenia: findings from a national clinical survey. J Psychiatr Pract. 12 (3), 139-47.
Härnryd, C., Bjerkenstedt, L., Gullberg, B., Oxenstierna, G., Sedvall, G. ,Wiesel, F. A.
1984. Time course for effects of sulpiride and chlorpromazine on monoamine metabolite and prolactin levels in cerebrospinal fluid from schizophrenic patients. Acta Psychiatr Scand Suppl. 311 75-92.
Ichiki, M., Kunugi, H., Takei, N., Murray, R. M., Baba, H., Arai, H., Oshima, I., Okagami, K., Sato, T., Hirose, T. ,Nanko, S. 2000. Intra-uterine physical growth in schizophrenia: evidence confirming excess of premature birth.
Psychol Med. 30 (3), 597-604.
Inskip, H. M., Harris, E. C. ,Barraclough, B. 1998. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry. 172 35-7.
Jentsch, J. D. ,Roth, R. H. 1999. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.
Neuropsychopharmacology. 20 (3), 201-25.
Jokinen, J., Nordström, A. L. ,Nordström, P. 2007. The relationship between CSF HVA/5-HIAA ratio and suicide intent in suicide attempters. Arch Suicide Res.
11 (2), 187-92.
Kelly, D. L., Shim, J. C., Feldman, S. M., Yu, Y. ,Conley, R. R. 2004. Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death. J Psychiatr Res. 38 (5), 531-6.
Kendell, R. E., Malcolm, D. E. ,Adams, W. 1993. The problem of detecting changes in the incidence of schizophrenia. Br J Psychiatry. 162 212-8.
Kessler, M., Terramani, T., Lynch, G. ,Baudry, M. 1989. A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem. 52 (4), 1319-28.
Kreyenbuhl, J. A., Kelly, D. L. ,Conley, R. R. 2002. Circumstances of suicide among individuals with schizophrenia. Schizophr Res. 58 (2-3), 253-61.
Kuo, C. J., Tsai, S. Y., Lo, C. H., Wang, Y. P. ,Chen, C. C. 2005. Risk factors for completed suicide in schizophrenia. Journal of Clinical Psychiatry. 66 (5), 579-85.
Laursen, T. M., Munk-Olsen, T., Nordentoft, M. ,Mortensen, P. B. 2007. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry. 68 (6), 899-907.
Lemus, C. Z., Lieberman, J. A., Johns, C. A., Pollack, S., Bookstein, P. ,Cooper, T. B.
1990. CSF 5-hydroxyindoleacetic acid levels and suicide attempts in schizophrenia. Biol Psychiatry. 27 (8), 926-9.
Lester, D. 1995. The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry. 28 (2), 45-50.
Lester, D. 2006. Sex differences in completed suicide by schizophrenic patients: a meta-analysis. Suicide Life Threat Behav. 36 (1), 50-6.
Lidberg, L., Belfrage, H., Bertilsson, L., Evenden, M. M. ,Asberg, M. 2000. Suicide attempts and impulse control disorder are related to low cerebrospinal fluid 5-HIAA in mentally disordered violent offenders. Acta Psychiatr Scand 101 (5), 395-402.
Limosin, F., Loze, J. Y., Philippe, A., Casadebaig, F. ,Rouillon, F. 2007. Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophr Res. 94 (1-3), 23-8.
Linderholm, K., Erhardt, S., Lindqvist, D., Janelidze, S., Hagell, P., Samuelsson, M., Träskman-Bendz, L. ,Brundin, L. (2009). Kynurenic acid in the cerebrospinal fluid of male suicide attempters - Increased levels in patients with MDD and correlations with cytokines. Program No. 305.5. 2009 Neuroscience Meeting Planner, 2009. Online. Chicago, IL, Society for Neuroscience.
MacDonald, A. W. ,Schulz, S. C. 2009. What we know: findings that every theory of schizophrenia should explain. Schizophr Bull. 35 (3), 493-508.
Mann, J. J., Malone, K. M., Psych, M. R., Sweeney, J. A., Brown, R. P., Linnoila, M., Stanley, B. ,Stanley, M. 1996. Attempted suicide characteristics and
cerebrospinal fluid amine metabolites in depressed inpatients.
Neuropsychopharmacology. 15 (6), 576-86.
Mann, J. J., Waternaux, C., Haas, G. L. ,Malone, K. M. 1999. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry. 156 (2), 181-9.
Mann, J. J. 2003. Neurobiology of suicidal behaviour. Nat Rev Neurosci. 4 (10), 819-828.
Mann, J. J. 2003. Neurobiology of suicidal behaviour. Nat Rev Neurosci. 4 (10), 819-28.
Mann, J. J., Currier, D., Stanley, B., Oquendo, M. A., Amsel, L. V. ,Ellis, S. P. 2006.
Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol. 9 (4), 465-74.
McGirr, A., Tousignant, M., Routhier, D., Pouliot, L., Chawky, N., Margolese, H. C.
,Turecki, G. 2006. Risk factors for completed suicide in schizophrenia and other chronic psychotic disorders: a case-control study. Schizophr Res. 84 (1), 132-43.
McGrath, J., Saha, S., Welham, J., El Saadi, O., MacCauley, C. ,Chant, D. 2004. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2 13.
McGrath, J., Saha, S., Chant, D. ,Welham, J. 2008. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 30 67-76.
McGrath, J. J. 2006. Variations in the incidence of schizophrenia: data versus dogma.
Schizophr Bull. 32 (1), 195-7.
Meltzer, H. Y., Alphs, L., Green, A. I., Altamura, A. C., Anand, R., Bertoldi, A., Bourgeois, M., Chouinard, G., Islam, M. Z., Kane, J., Krishnan, R., Lindenmayer, J. P. ,Potkin, S. 2003. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry. 60 (1), 82-91.
Mortensen, P. B. ,Juel, K. 1993. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry. 163 183-189.
Munk-Jörgensen, P. ,Mortensen, P. B. 1992. Incidence and other aspects of the epidemiology of schizophrenia in Denmark, 1971-87. Br J Psychiatry. 161 489-95.
NASP. (2008). "NASP Karolinska Insititutet www.ki.se/nasp."
Nilsson-Todd LK, N. C., Jönsson EG, Skogh E, Erhardt S. 2007. Cerebrospinal fluid kynurenic acid in male patients with schizophrenia – correlation with monoamine metabolites. Acta Neuropsychiatrica. ( 19), 45–52.
Nilsson, L. K., Linderholm, K. R., Engberg, G., Paulson, L., Blennow, K., Lindstrom, L. H., Nordin, C., Karanti, A., Persson, P. ,Erhardt, S. 2005. Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia.
Schizophr Res. 80 (2-3), 315-22.
Ninan, P. T., van Kammen, D. P., Scheinin, M., Linnoila, M., Bunney, W. E., Jr.
,Goodwin, F. K. 1984. CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. Am J Psychiatry. 141 (4), 566-9.
Nordström, P., Samuelsson, M., Åsberg, M., Träskman-Bendz, L., Åberg-Wistedt, A., Nordin, C. ,Bertilsson, L. 1994. CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav. 24 (1), 1-9.
Oxenstierna, G., Bergstrand, G., Edman, G., Flyckt, L., Nybäck, H. ,Sedvall, G. 1996.
Increased frequency of aberrant CSF circulation in schizophrenic patients compared to healthy volunteers. Eur Psychiatry. 11 (1), 16-20.
Palmer, B. A., Pankratz, V. S. ,Bostwick, J. M. 2005. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psych. 62 (3), 247-53.
Parsons, C. G., Danysz, W., Quack, G., Hartmann, S., Lorenz, B., Wollenburg, C., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Chizh, B. ,Headley, P.
M. 1997. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization. J Pharmacol Exp Ther. 283 (3), 1264-75.
Pickar, D., Roy, A., Breier, A., Doran, A., Wolkowitz, O., Colison, J. ,Agren, H. 1986.
Suicide and aggression in schizophrenia. Neurobiologic correlates. Ann N Y Acad Sci. 487 189-96.
Placidi, G. P., Oquendo, M. A., Malone, K. M., Huang, Y. Y., Ellis, S. P. ,Mann, J. J.
2001. Aggressivity, suicide attempts, and depression: relationship to
cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry. 50 (10), 783-91.
Pompili, M., Amador, X. F., Girardi, P., Harkavy-Friedman, J., Harrow, M., Kaplan, K., Krausz, M., Lester, D., Meltzer, H. Y., Modestin, J., Montross, L. P., Mortensen, P. B., Munk-Jorgensen, P., Nielsen, J., Nordentoft, M., Saarinen, P.
I., Zisook, S., Wilson, S. T. ,Tatarelli, R. 2007. Suicide risk in schizophrenia:
learning from the past to change the future. Ann Gen Psychiatry. 6 10.
Pompili, M., Amador, X. F., Girardi, P., Harkavy-Friedman, J., Harrow, M., Kaplan, K., Krausz, M., Lester, D., Meltzer, H. Y., Modestin, J., Montross, L. P., Mortensen, P. B., Munk-Jorgensen, P., Nielsen, J., Nordentoft, M., Saarinen, P.
I., Zisook, S., Wilson, S. T. ,Tatarelli, R. 2007. Suicide risk in schizophrenia:
learning from the past to change the future. Ann Gen Psychiatry. 6 10.
Preston, E. ,Hansen, L. 2005. A systematic review of suicide rating scales in schizophrenia. Crisis. 26 (4), 170-80.
Radomsky, E. D., Haas, G. L., Mann, J. J. ,Sweeney, J. A. 1999. Suicidal behavior in patients with schizophrenia and other psychotic disorders. Am J Psychiatry. 156 (10), 1590-5.
Ran, M. S., Chen, E. Y., Conwell, Y., Chan, C. L., Yip, P. S., Xiang, M. Z. ,Caine, E.
D. 2007. Mortality in people with schizophrenia in rural China: 10-year cohort study. Br J Psychiatry. 190 237-42.
Reutfors, J., Brandt, L., Jönsson, E. G., Ekbom, A., Sparen, P. ,Ösby, U. 2009. Risk factors for suicide in schizophrenia: findings from a Swedish population-based case-control study. Schizophr Res. 108 (1-3), 231-7.
Roggenbach, J., Muller-Oerlinghausen, B. ,Franke, L. 2002. Suicidality, impulsivity and aggression--is there a link to 5HIAA concentration in the cerebrospinal fluid? Psychiatr Res. 113 (1-2), 193-206.
Roy, A. 1982. Suicide in chronic schizophrenia. Br J Psychiatry. 141 171-7.
Roy, A., Ninan, P., Mazonson, A., Pickar, D., Van Kammen, D., Linnoila, M. ,Paul, S.
M. 1985. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide. Psychol Med. 15 (2), 335-40.
Roy, A., Ågren, H., Pickar, D., Linnoila, M., Doran, A. R., Cutler, N. R. ,Paul, S. M.
1986. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. Am J Psychiatry. 143 (12), 1539-1545.
Saha, S., Chant, D. ,McGrath, J. 2007. A systematic review of mortality in
schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry. 64 (10), 1123-1131.
Schwarcz, R., Rassoulpour, A., Wu, H. Q., Medoff, D., Tamminga, C. A. ,Roberts, R.
C. 2001. Increased cortical kynurenate content in schizophrenia. Biol Psychiatry. 50 (7), 521-30.
Sedvall, G. C. ,Wode-Helgodt, B. 1980. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients. Arch Gen Psychiatry. 37 (10), 1113-6.
Seeman, M. V. 2007. An outcome measure in schizophrenia: mortality. Can J Psychiatry. 52 (1), 55-60.
Sewell, R. A., Ranganathan, M. ,D'Souza, D. C. 2009. Cannabinoids and psychosis. Int Rev Psychiatry. 21 (2), 152-62.
Sinclair, J. M., Mullee, M. A., King, E. A. ,Baldwin, D. S. 2004. Suicide in
schizophrenia: a retrospective case-control study of 51 suicides. Schizophr Bull.
30 (4), 803-11.
Stanley, B., Molcho, A., Stanley, M., Winchel, R., Gameroff, M. J., Parsons, B. ,Mann, J. J. 2000. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am J Psychiatry. 157 (4), 609-614.
Stanley, M. ,Mann, J. J. 1983. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet. 1 (8318), 214-6.
Stanley, M., Traskman-Bendz, L. ,Dorovini-Zis, K. 1985. Correlations between aminergic metabolites simultaneously obtained from human CSF and brain.
Life Sci. 37 (14), 1279-86.
Statistics Sweden. (2009). "Mean life expectancy for general population 50 years of age 2003-2007. Statistics Sweden 2009."
Suominen, K., Isometsä, E., Suokas, J., Haukka, J., Achte, K. ,Lönnqvist, J. 2004.
Completed suicide after a suicide attempt: a 37-year follow-up study. Am J Psychiatry. 161 (3), 562-3.
Swahn, C. G., Sandgarde, B., Wiesel, F. A. ,Sedvall, G. 1976. Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method. Psychopharmacology (Berl).
48 (2), 147-153.
Taiminen, T., Huttunen, J., Heilä, H., Henriksson, M., Isometsa, E., Kahkonen, J., Tuominen, K., Lönnqvist, J., Addington, D. ,Helenius, H. 2001. The
Schizophrenia Suicide Risk Scale (SSRS): development and initial validation.
Schizophr Res. 47 (2-3), 199-213.
Tidemalm, D., Långström, N., Lichtenstein, P. ,Runeson, B. 2008. Risk of suicide after suicide attempt according to coexisting psychiatric disorder: Swedish cohort study with long term follow-up. BMJ. 337 a2205.
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A.
,Haukka, J. 2009. 11-year follow-up of mortality in patients with schizophrenia:
a population-based cohort study (FIN11 study). Lancet. 374 (9690), 620-7.
Träskman-Bendz, L., Åsberg, M., Bertilsson, L. ,Thoren, P. 1984. CSF monoamine metabolites of depressed patients during illness and after recovery. Acta Psychiatr Scand. 69 (4), 333-42.
Träskman-Bendz, L., Alling, C., Oreland, L., Regnell, G., Vinge, E. ,Öhman, R. 1992.
Prediction of suicidal behavior from biologic tests. J Clin Psychopharmacol. 12 (2 Suppl), 21S-26S.
Träskman, L., Åsberg, M., Bertilsson, L. ,Sjostrand, L. 1981. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry. 38 (6), 631-6.
Turecki, G. 2005. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J Psychiatry Neurosci. 30 (6), 398-408.
van Heeringen, C. 2001. Suicide, serotonin, and the brain. Crisis. 22 (2), 66-70.
Van Heeringen, C. ,Marusic, A. 2003. Understanding the suicidal brain. Br J Psychiatry. 183 282-4.
van Os, J. ,Kapur, S. 2009. Schizophrenia. Lancet. 374 (9690), 635-45.
van Praag, H. M. 1983. CSF 5-HIAA and suicide in non-depressed schizophrenics.
Lancet. 2 (8356), 977-8.
Vares, M., Ekholm, A., Sedvall, G. C., Hall, H. ,Jönsson, E. G. 2006. Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures. Psychopathology. 39 (6), 286-95.
WHO. (2008). "World Health Organization (WHO) www.who.int."
Wode-Helgodt, B., Fyrö, B., Gullberg, B. ,Sedvall, G. 1977. Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients. Acta Psychiatr Scand 56 (2), 129-142.
Yarden, P. E. 1974. Observations on suicide in chronic schizophrenics. Compr Psychiatry. 15 (4), 325-33.
Ågren, H., Mefford, I. N., Rudorfer, M. V., Linnoila, M. ,Potter, W. Z. 1986.
Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF. J Psychiatr Res. 20 (3), 175-93.
Åsberg, M., Träskman, L. ,Thoren, P. 1976. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry. 33 (10), 1193-7.
Åsberg, M. 1997. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann N Y Acad Sci. 836 158-81.
Ösby, U., Correia, N., Brandt, L., Ekbom, A. ,Sparen, P. 2000. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res. 45 (1-2), 21-28.